Michael Gelband’s Tricida, Inc. Common Stock TCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-134,857
Closed -$1.11M 2688
2022
Q1
$1.11M Buy
134,857
+95,258
+241% +$862K 0.01% 1085
2021
Q4
$379K Buy
+39,599
New +$255K ﹤0.01% 1558
2021
Q3
Sell
-27,220
Closed -$118K 2849
2021
Q2
$118K Buy
+27,220
New +$130K ﹤0.01% 2117
2020
Q4
Sell
-28,947
Closed -$262K 2515
2020
Q3
$262K Buy
+28,947
New +$423K 0.01% 1348
2020
Q1
Sell
-30,791
Closed -$1.16M 1798
2019
Q4
$1.16M Buy
30,791
+12,957
+73% +$483K 0.02% 498
2019
Q3
$551K Buy
+17,834
New +$597K 0.02% 618

Other funds holding TCDA

Michael Gelband's TCDA Position: Q2 2022 in Review

Michael Gelband sold out of Tricida, Inc. Common Stock (TCDA) in Q2 2022, closing a stake of 134,857 shares — an estimated $1.11M sold.

Michael Gelband first reported a position in TCDA in Q3 2019 and held it in 6 quarters. The position peaked at $1.16M in Q4 2019. 114 funds tracked by Wall St. Rank hold TCDA as of Q2 2022.

  • Michael Gelband reported no remaining Tricida, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Michael Gelband sold 134,857 Tricida, Inc. Common Stock shares in Q2 2022, an estimated $1.11M.
  • Michael Gelband first reported a position in Tricida, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • Michael Gelband's Tricida, Inc. Common Stock position peaked at $1.16M in Q4 2019.
  • 114 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.